Donahue, J.F.

organ sarcoidosi infliximab extrapulmonary patient study group epost score involvement extrapulmonary sarcoidosis treatment placebo number severity infliximab groups baseline extrapulmonary organ involvement university epost score change extrapulmonary organs therapy system table judson organ involvement efficacy investigator sarcoidosis vasc epostadj placebo group 24 weeks randomised assessment disease center journal european trial corticosteroids physician epost scores effect treatment groups volume infusion treatment group hospital lymph nodes baughman week 24. infliximab therapy week 24 subject end-point improvement lymph comparison result cleveland clinic foundation 17 extrapulmonary organs chest journal m.a week 24 placebo university hospital maastricht visit 3 mg ?kg tnf-a medicine research respir week 0 severity tool sample sizes novel severity tool epostadj score muscle spleen /joint